Sort
10,766 grants matching “checkpoint inhibitor”
PTP1b Inhibition Restores the Innate Anti-tumor Response During Chemotherapy
$301,996Eric S Ubil · University Of Alabama At Birmingham · R01 · FY2023 · CA
"Optimizing synthetic lethality in high-grade serous ovarian cancer"
$301,950Fiona Simpkins · Johns Hopkins University · P50 · FY2022 · CA
Mechanisms of UV-induced skin carcinogenesis
$301,888Laura A Hansen · Creighton University · R01 · FY2010 · ES
Role of T Regulatory Cell Suppression in Autoimmunity and Cancer
$301,885Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Development of a B Cell Based Vaccine for the Treatment of Newly Diagnosed Malignant Gliomas
$301,832Catalina Lee Chang · Northwestern University At Chicago · P50 · FY2023 · CA
Radioimmunotherapy Combinations for B-cell Malignancy
$301,797Damian J. Green · University Of Miami School Of Medicine · R01 · FY2024 · CA
Large-Scale Genetic Analyses of Human Cancer
$301,791Victor E Velculescu · Johns Hopkins University · R01 · FY2019 · CA
Project 4: Combined use of immunotherapy and targeted treatments for triple negative breast cancer
$301,775Kornelia Polyak · Dana-Farber Cancer Inst · P50 · FY2023 · CA
Checkpoint inhibitor treatment for EBV+ lymphoma among HIV+ individuals
$301,675Mark Roschewski · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Project 2: Measuring and modeling the tumor and immune microenvironment before and during therapy and at the time of drug resistance
$301,411Arlene H Sharpe · Harvard Medical School · U54 · FY2022 · CA
Targeting Cell Cycle Machinery For Cancer Therapy
$301,275E Premkumar Reddy · Temple Univ Of The Commonwealth · R01 · FY2006 · CA
Tumor Suppressor Qualities and Mechanisms of LZAP Activity
$301,256Wendell G Yarbrough · Vanderbilt University · R01 · FY2012 · DE
Molecular Pharmacology & Biochemistry of Dual Specificity Phosphatase Inhibitors
$300,978John S Lazo · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · CA
Mechanisms of Telomere Function
$300,820New York University School Of Medicine · R01 · FY2004 · CA
Roles of Lig3 and XRCC1 Genes in Genome Stability
$300,713Alan E Tomkinson · University Of Maryland Baltimore · R01 · FY2010 · ES
Role of RecQ Helicases to Prevent Senescence By c-Myc
$300,693Carla Grandori · Fred Hutchinson Cancer Research Center · R01 · FY2010 · AG
Therapeutic targeting of stratifin structure and function
$300,665Jian-Ting Zhang · Indiana University Indianapolis · R01 · FY2014 · CA
Georgetown University Lombardi Comprehensive Cancer Center Support Grant
$300,625Louis M Weiner · Georgetown University · P30 · FY2022 · CA
Project 1: Imaging, pathology, and molecular biomarkers to Optimize Treatment Switching within a SMART adaptive Framework
$300,575Angela Demichele · University Of California, San Francisco · P01 · FY2025 · CA
Mechanisms of Telomere Function
$300,449New York University School Of Medicine · R01 · FY2003 · CA
MTOR as a Therapeutic Target in Childhood Cancer
$300,375St. Jude Children'S Research Hospital · R01 · FY2003 · CA
MTOR as a Therapeutic Target in Childhood Cancer
$300,375St. Jude Children'S Research Hospital · R01 · FY2002 · CA
MTOR as a Therapeutic Target in Childhood Cancer
$300,375St. Jude Children'S Research Hospital · R01 · FY2004 · CA
MTOR as a Therapeutic Target in Childhood Cancer
$300,375St. Jude Children'S Research Hospital · R01 · FY2005 · CA
Project 3: Investigating new treatment approaches based on DNA repair vulnerability in ARID1A mutated type I ovarian cancer
$300,357Stephanie Gaillard · Johns Hopkins University · P50 · FY2025 · CA